Two Chromatin Remodeling Activities Cooperate during Activation of Hormone Responsive Promoters by Vicent, Guillermo Pablo et al.
Two Chromatin Remodeling Activities Cooperate during
Activation of Hormone Responsive Promoters
Guillermo Pablo Vicent
1., Roser Zaurin









1Centre de Regulacio ´ Geno `mica (CRG), Universitat Pompeu Fabra, Parc de Recerca Biome `dica (PRBB), Barcelona, Spain, 2Department of Proteomics and Signal
Transduction, Max Planck Institute for Biochemistry, Martinsried, Germany, 3Department of Physiological Chemistry and Cancer Genomics Centre, University Medical
Center Utrecht, Utrecht, The Netherlands
Abstract
Steroid hormones regulate gene expression by interaction of their receptors with hormone responsive elements (HREs) and
recruitment of kinases, chromatin remodeling complexes, and coregulators to their target promoters. Here we show that in
breast cancer cells the BAF, but not the closely related PBAF complex, is required for progesterone induction of several
target genes including MMTV, where it catalyzes localized displacement of histones H2A and H2B and subsequent NF1
binding. PCAF is also needed for induction of progesterone target genes and acetylates histone H3 at K14, an epigenetic
mark that interacts with the BAF subunits by anchoring the complex to chromatin. In the absence of PCAF, full loading of
target promoters with hormone receptors and BAF is precluded, and induction is compromised. Thus, activation of
hormone-responsive promoters requires cooperation of at least two chromatin remodeling activities, BAF and PCAF.
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Introduction
Regulation of eukaryotic gene expression implies mechanisms
that permit transcription factors to gain access to chromatin
packaged DNA sequences. The basic unit of chromatin, the
nucleosome, consists of an octamer formed of two copies of each of
the four core histones (H2A, H2B, H3, and H4) around which
147 bp DNA is wrapped in 1.65 left-handed superhelical turns [1].
Modulation of the structure and dynamics of nucleosomes is an
important regulatory mechanism in all DNA-based processes and
is catalyzed by chromatin remodeling complexes. Such complexes
can either modify histone residues or use the energy of ATP
hydrolysis to alter the relationship between histones and DNA
[2,3].
The yeast SWI/SNF complex, the first ATP-dependent
chromatin remodeling complex to be identified, is a 2-MDa
complex of 11 subunits that regulates gene expression by
catalyzing octamer transfer, nucleosome sliding, dinucleosome
formation, and H2A/H2B displacement [4–6]. RSC, (Remodel
the Structure of Chromatin) [7], is a closely related yeast
chromatin remodeling complex of 15 subunits, that shares two
identical and at least four homologous subunits with the ySWI/
SNF complex [8]. There are two human SWI/SNF-like
complexes both containing ATPase subunits similar to yeast
Swi2/Snf2, hBRM (human Brahma) or BRG1 (Brahma-Related
Gene 1), as well as a series of other subunits, some of which differ
in various cell types [8]. The hSWI/SNF-a complexes, also called
BAF for BRG1/hBRM-Associated Factor, contain either hBRM
or BRG1 as ATPase and is orthologue to yeast SWI/SNF. The
hSWI/SNF-b complex, also called PBAF (Polybromo-associated
BAF) contains only hBRG1 and is orthologue to yeast RSC
complex [4,9]. The BAF and PBAF complexes share many
subunits but have also subtype specific subunits: BAF250 and
hBRM are only found in BAF, whrereas BAF180 and BAF 200
are only found in PBAF [4,10]. BAF57 has been reported as a
common subunit for BAF and PBAF complexes [4,9].
Histone acetyltransferases (HATs) and histone deacetylases
(HDACs) represent other group of chromatin remodeling
complexes that regulate the level of acetylation on the N-terminal
tails of core histone proteins and other protein substrates [11,12].
The HATs are divided into five families, including the GCN5-
related N-acetyltransferases (GNATs) with GCN5 and PCAF as
the best characterized members; the MYST (’MOZ, Ybf2/Sas3,
Sas2 and Tip60)-related HATs; p300/CREB-binding protein
(CBP) HATs; the general transcription factor HATs including the
TFIID subunit TBP-associated factor-1 (TAF1); and the nuclear
hormone-related HATs SRC1 and ACTR (SRC3) [13,14].
Recombinant PCAF, like full-length GCN5, acetylates either free
histones or nucleosomes [15], primarily on lysine -14 of histone H3
[16]. The role of PCAF in transcription has been investigated in
multiple studies, and its requirement as a HAT and coactivator
has been described in several processes including nuclear receptor
PLoS Genetics | www.plosgenetics.org 1 July 2009 | Volume 5 | Issue 7 | e1000567mediated events [17,18], but the precise mechanism of action has
not yet been elucidated.
The functional relationship between different chromatin remod-
eling enzymatic activities is of great interest. A remarkable
interdependence has been described during transcriptional activa-
tion in S. cerevisiae between the SWI/SNF complex and the histone
acetylation complex SAGA [19]. Bromodomains of the RSC
complex have been shown to recognize acetylated H3K14 [20].
HATactivitystabilizesSWI/SNFbinding topromoternucleosomes
providing a mechanistic basis for the ordered recruitment of these
complexes [21]. In mammalian cells, transcriptional activation by
nuclear receptors requires multiple cofactors including CBP/p300,
SWI/SNF and Mediator. The ordered recruitment of these
cofactors to the promoters depends not only on the direct
interactions between nuclear receptors and cofactors but also on
cofactor-cofactor interaction and on histone modifications [22].
Gene regulation by steroid hormones is mediated by intracel-
lular receptors, which upon hormone binding can activate signal
transduction cascades and interact in the nucleus with other
transcription factors and/or with dedicated DNA sequences,
called hormone responsive elements (HREs) [23]. When ligand-
receptor complexes interact with HREs they alter the transcrip-
tional state of the associated genes via the recruitment of
chromatin remodeling complexes and other coregulators to the
target promoters [24,25]. The mouse mammary tumor virus
(MMTV) long terminal-repeat region encompasses a promoter
including within 140 bp five degenerated hormone responsive
elements (HREs) and a binding site for nuclear factor 1 (NF1). In
chromatin the MMTV promoter is organized into positioned
nucleosomes [26], with a nucleosome located over the five HREs
and the NF1 binding site [27]. On this promoter nucleosome, the
binding site for NF1 is not accessible and only two of the five
HREs, the strong palindromic HRE1 and the weak half
palindrome HRE4, can be bound by hormone receptors, while
the central HREs, in particular the palindromic HRE2 and the
half palindrome HRE3, are not accessible for receptor binding
[28]. Following hormone induction in vivo all HREs and the
binding site for NF1 are occupied simultaneously on the surface of
a nucleosome-like structure and a functional synergism is observed
between progesterone receptor (PR) and NF1 [27].
Already 5 minutes after addition of hormone to breast cancer
cells with an integrated copy of an MMTV-luc reporter, the
cytoplasmic signaling cascade Src/Ras/Erk is activated via an
interaction of PR with the estrogen receptor, which activates Src
[29]. As a consequence of Erk activation, PR is phosphorylated,
Msk1 is activated, and a ternary complex PR-Erk-Msk1 is
recruited to nucleosome B [30]. Msk1 phosphorylates H3 at
serine 10, a modification which is accompanied by acetylation at
H3 lysine 14, displacement of HP1c, and recruitment of RNA
polymerase II [30]. Inhibition of Erk or Msk activation blocks
H3S10 phosphorylation, H3K14 acetylation, and hormonal
induction of MMTV and other progesterone target genes [30].
There have been several reports indicating a role for SWI/SNF,
Brg1 and Brm in glucocorticoid regulation of MMTV transcription
[31–33], but the situation with progesterone is less clear. The
MMTV promoter assembled in minichromosomes with positioned
nucleosomes [34] is activatedbyPR ina processinvolvinga NURF-
dependent mutual synergism between PR and NF1 [35]. Proges-
terone treatment of a breast cancer cell line carrying a single
integrated copy of a MMTV transgene leads to recruitment of PR,
SWI/SNF, and SNF2h-related complexes totheMMTV promoter,
accompanied by selective displacement of histones H2A and H2B
from nucleosome B [6,25]. Recently, the acidic N terminus of the
Swi3p subunit of yeast SWI/SNF was identified as a novel H2A-
H2B-binding domain required for ATP-dependent H2A/H2B
dimer displacement [36]. Moreover, a characteristic and sharp
DNase I hypersensitive site appears near the symmetry axis of the
nucleosome encompassing the HREs [27]. The same hypersensitive
site can be induced in the absence of hormone by treatment with
low concentrations of histone deacetylases inhibitors, such as
sodium butyrate or trichostatin A [37], suggesting that it can be
initiated by a moderate increased in histone acetylation. However,
the relationship between histone acetylation and ATP-dependent
nucleosome remodeling following hormone treatment is not clear.
To approach this question we have performed knockdown and
ChIP experiments targeting human SWI/SNF complexes and
histone acetyl transferases (HATs) in breast cancer cells.
Results
BAF is required for progesterone gene activation in
T47D-MTVL cells and is recruited to the MMTV promoter
upon induction
The requirement of Brm and Brg1 for MMTV promoter
activation was assessed in T47D-MTVL cells transfected with
specific siRNAs. When siRNA against Brg1 was used, the levels of
Brm protein increased (Figure 1A, left panels) and viceversa
(Figure 1A, middle panels). A significant reduction (80% and 55%
for Brm and Brg1, respectively) of both ATPases was only
observed when the two siRNAs were combined (Figure 1A, right
panels). The levels of the two PR isoforms, PRB and PRA, were
unaffected by Brg1 or Brm siRNAs (Figure 1A, third row). In cells
transfected with control siRNA an eight-fold increase in MMTV-
luc transcription was observed 8 hours after hormone treatment
(Figure 1B). In cells transfected with siRNAs against either Brg1 or
Brm, the induction was reduced by 30% and 20% respectively,
whereas transfection of both siRNA simultaneously reduced the
induction of the MMTV promoter by 60%, confirming the
essential role of hSWI/SNF on MMTV promoter activation
(Figure 1B). Progestin induction of MYC and FOS, two other
progesterone target genes, was also impaired by the combined
siRNAs to a level similar to that observed with MMTV-luc
(Figure 1C). However, not all hormone-dependent genes required
SWI/SNF, as the combined siRNAs did not inhibit the progestin
induction of the cyclin D1 gene (Figure 1C).
To identify the nature of the Brm/Brg1-containing complex in
T47D-MTVL cells, we performed western blotting against
subunits of BAF and PBAF, the two distinctive hSWI/SNF
complexes. Subunits of both complexes exist in T47D-MTVL cells
Author Summary
In order to adapt its gene expression program to the
needs of the environment, the cell must access the
information stored in the DNA sequence that is tightly
packaged into chromatin in the cell nucleus. How the cell
manages to do it in a selective maner is still unclear. Here
we show that, in breast cancer cells treated with the
ovarian hormone progesterone, the hormone receptor
recruits to the regulated genes two chromatin remodeling
complexes that cooperate in opening the chromatin
structure. One of the complexes puts a mark in a
chromatin protein that anchors the other complex,
enabling full gene activation. The present discovery
highlights the importance of the concerted order of
events for access to genomic information during activation
of gene expression and reveals the intricacies of hormonal
gene regulation.
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PLoS Genetics | www.plosgenetics.org 2 July 2009 | Volume 5 | Issue 7 | e1000567Figure 1. BAF is essential for MMTV promoter activity in T47D-MTVL cells. (A) Cells were transfected either with siRNA against Brg1, Brm ,
or both siRNAs combined as indicated. After 48 h the medium was replaced by fresh medium without serum. After one day in serum-free conditions,
cells were lysed and the levels of Brm, Brg1, PR and tubulin were determined by Western blotting. C, control siRNA. (B) Cells were transfected with
Control, Brg1 and Brm siRNAs as described in (A). After one day in serum-free conditions, cells were incubated with 10 nM R5020 for 8 hs and total
RNA was prepared, cDNA was generated and used as template for real time PCR with luciferase oligonucleotides. The values represent the mean and
standard deviation from 3 experiments performed in duplicate. (C) Cells were transfected with Control, Brg1 and Brm siRNAs as described in (A) and
treated with 10 nM R5020. cDNA was generated and used as template for real-time PCR using specific c-Fos, c-Myc, Cyclin D1 and GAPDH primers.
The values represent the mean6SD of 3 experiments performed in duplicate. (D) Cells were transfected with Control and BAF57 siRNAs as described
in (A) and treated with 10 nM R5020. Left: BAF57 levels were analyzed by Western blotting. Right: RNA was extracted, cDNA was generated and used
as template for real time PCR with luciferase oligonucleotides. The values represent the mean6SD of 2 experiments performed in duplicate. (E)
Experiments similar to those shown in (D), but cells were transfected with Control and BAF250 siRNAs as described in (A) and (D). The values
represent the mean6SD of 2 experiments performed in duplicate. (F) Cells were lysed and immunoprecipitated either with a-BAF57 antibody or with
normal rabbit IgG as a negative control (IgG). The immunoprecipitates (IP) were analyzed by western blotting with non-discriminating Brg1/Brm
antibody, a-BAF155 or a-BAF170 specific antibodies. (G) Cells were untreated (0) or treated for 5, 30 or 60 min with 10 nM R-5020 and subjected to
ChIP assays with a-PR, a-Brg1, a-Brm, a-BAF57, a-BAF250, a-BAF180 and a-BAF200 specific antibodies. The precipitated DNA fragments were
subjected to PCR analysis to test for the presence of sequences corresponding to the MMTV nucleosome B. Input material (1%) is shown for
comparison. A representative of three independent experiments is shown.
doi:10.1371/journal.pgen.1000567.g001
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BAF and PBAF. The specific subunits that distinguish the two
complexes are Brm and BAF250 for BAF, and BAF180 and
BAF200 for PBAF. Knocking down BAF57 and BAF250 levels by
approximately 50% resulted in a similar reduction in the
hormonal induction of the MMTV promoter without changes in
Brg1 and Brm protein levels (Figure 1D and 1E and data not
shown). Co-immunoprecipitation experiments demonstrated that
in T47D-MTVL cells BAF57 forms a complex with the core
subunits BAF155, BAF170, BAF 180 and the ATPases Brg1 and
Brm (Figure 1F, lane 2 and data not shown). We conclude that
BAF and PBAF complexes in the breast cancer cell lines used for
these studies contain BAF57.
To further identify the specific complex recruited to the MMTV
promoter, we performed ChIP experiments using antibodies
recognizing specific components of the BAF and PBAF complexes.
Simultaneously with the recruitmentof PR tothe MMTVpromoter
after hormone treatment, we observed recruitment of Brg1, Brm,
BAF250andBAF57(Figure 1G).Incontrast,BAF180andBAF200,
two of the specific subunits of PBAF, were not recruited to the
MMTV promoter after hormone treatment (Figure 1G, third and
fourth rows from the bottom), while they were recruited to the
RARb2 promoter after retinoic acid treatment in U937 cells (Figure
S2A). Moreover, siRNA mediated downregulation of BAF180 in
T47D-MTVL cells did no influenced hormonal induction of the
MMTV promoter (Figure S2B). Thus, BAF complexes containing
either one of the two related ATPases together with BAF250 and
BAF57 are recruited to the MMTV promoter along with PR and
likely mediate promoter transactivation.
BAF57 and BAF250 interact with progesterone receptor
in T47D-MTVL cells
BAF57 has been shown to directly interact with the androgen
and estrogen receptors [38,39]. We used co-immunoprecipitation
experiments to test whether BAF57 forms a complex with PR in
cultured cells. In the absence of hormone, a certain proportion of
BAF57 already coprecipitated with PR probably due to the large
proportion of PR molecules already present in the nucleus in the
uninduced state; however 30 minutes after hormone addition the
extent of coprecipitation was increased (Figure 2A, lanes 4 and 5).
In contrast, no complex of PR with the PBAF specific subunit,
BAF180 was observed independently of the addition of the
hormone (Figure 2B). As a positive control for this experiment we
used BAF250, a known BAF specific subunit [40]. BAF250 as
BAF57 also showed a hormone-dependent interaction with PR
(Figure 2B, lanes 2 and 3).
The PR-BAF57 interaction is likely direct, as activated ligand-
bound PR interacts with GST-BAF57 in pull-down studies
(Figure 2D, lane 2). Deletion mutants lacking either the C-
terminal domain or the N-terminal domain, or containing only the
central NHRLI domain (Figure 2C, left panel), could not form a
complex with PR in GST-pulldown experiments (Figure 2D top
row, lanes 3–5).
The fact that BAF57 ispresentinboth BAFandPBAF complexes
butonly BAFis recruitedto the targetpromotersindicate that either
the PR-BAF57 interaction is not sufficient for recruitment of the
complex or BAF57 can only interact with PR in the context of the
BAF complex but not when integrated in the PBAF complex.
Acetylation on histone H3K14 by PCAF is required for
hormonal induction
As the central ATPases of the BAF complex, Brg1 and Brm,
both contain bromodomains that recognize acetylated lysines
[41,42] and have been shown to bind acetylated histone H3 and
H4 tails [43,44], we wondered about possible roles of histone
acetyltransferases (HATs) in hormone induction. Using siRNAs we
knocked down PCAF and/or SRC1, which are known to be
recruited to the MMTV promoter upon induction [6,30]
(Figure 3A). We do not have an explanation for the enhancement
of the unspecific band (marked with an asterisk in Figure 3A, first
row, lanes 2 and 4). When siPCAF was used, there was a 50%
reduction of the MMTV induction (Figure 3A, right panel)
paralleling the decrease in PCAF protein (Figure 3A, left panel),
whereas siSRC1 caused only a 15% decrease (Figure 3A, right
panel). The combination of the two siRNAs decreased induction
by 62% (Figure 3A, right panel), indicating that PCAF is the more
relevant HAT in hormonal activation of MMTV. PCAF depletion
also decreased induction of other progesterone target genes such as
MYC and FOS (Figure 3B), which were shown to depend on BAF.
The need for the catalytic activity of PCAF in regulating
MMTV promoter was studied in T47D-MTVL cells transfected
with wild type PCAF or an enzymatic deficient mutant
(PCAFDHAT). While transfection of wild type PCAF further
increased the level of activity obtained after hormone addition,
transfection of PCAFDHAT did not further stimulate the MMTV
promoter (Figure 3C). Although PCAF and PCAFDHAT are
expressed at similar levels (data not shown), PCAFDHAT does not
act as a dominant negative mutant possibly because its levels are
not sufficient to compete with endogenous PCAF in transient
transfection. Similar results were obtained when MYC and FOS
genes were analysed (data not shown). Thus, the catalytic activity
of PCAF is required for transcriptional activation of those
progestin target genes, which induction depends on BAF.
Regarding other acetyl transferases, no decrease in hormone-
dependent activation of the MMTV was observed after transfec-
tion with specific siRNAs against GCN5 (data not shown).
Acetylated H3 lysine 14 anchors the BAF complex on the
promoter
We next tested the influence of histone acetylation on BAF
recruitment to the MMTV promoter. In control cells hormone
treatment induced increased acetylation of H3K14 accompanied
by recruitment of BAF57 and BAF250, whereas knockdown of
PCAF and SRC1 abrogated K14 acetylation and markedly
reduced BAF57 and BAF250 loading on the promoter
(Figure 3D, compare lanes 1–2 vs 3–4; quantification by real
time PCR is shown in the right panel). To test whether H3K14
acetylation and BAF binding take place on the same promoter, we
performed sequential ChIP (re-ChIP) experiments in the MMTV,
FOS and the MYC promoters. Hormone treatment induced
increased acetylation of H3K14 accompanied by recruitment of
BAF250 to the corresponding promoters (Figure 3E, lanes 5 and
6), indicating that the H3K14 acetylation and BAF recruitment
occur in the same genomic region. In contrast, control re-ChIPs
performed with irrelevant IgG as first antibody showed no
amplification product (Figure 3E, lanes 3 and 4).
To test whether the association of H3K14 acetylation and BAF
is a general phenomenon, we performed co-immunoprecipitation
of total hormone-treated chromatin followed by western blot. This
seems to be the case, as immunoprecipitation with antibody
against acetylated H3K14 co-precipitated BAF155 (Figure 3F) and
Brg1 (data not shown).
We next used pull-down experiments with T47D-MTVL
nuclear extracts and biotinylated peptides of H3 and H4 tails
containing various modifications to test whether H3K14 acetyla-
tion influences the binding affinity of the BAF complex for histone
tails. Histone H1 was used as loading control (Figure 4A, lower
BAF and PCAF Cooperate in MMTV Induction
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nearly all subunits of the BAF and PBAF complexes, namely Brg1,
Brm, BAF170, BAF155, BAF57, BAF180 and SNF5 (Figure 4A,
lanes 4, 5, 7, and 8). Similar results were also obtained using HeLa
nuclear extracts (data not shown). Moreover, binding of BAF and
PBAF complexes to H3 peptides depends solely on H3K14ac and
it is not affected by acetylation, phosphorylation or methylation of
adjacent residues. Peptides carrying additional modifications, such
as K4me3, K9ac, K9me3, or S10p, exhibited similar affinity for
BAF subunits as those carrying only K14ac (Figure 4A lanes 5, 7, 8
and data not shown). H3 peptides acetylated at K9 and pan-
acetylated (K5, 8, 12, 16) H4 peptides did not exhibit preferential
BAF affinity (Figure 4A lanes 3, 10 and 11). Although H4K8
acetylation takes place very early after progesterone addition to
T47D-MTVL cells (Figure 4B, upper panel), we found here no
binding of the BAF complex to acetylated H4 peptides. The PBAF
specific subunit, BAF180 showed the same behaviour as the BAF
subunits when incubated with the modified peptides (Figure 4A,
third row from the top). It is important to note, that we detected a
faint and consistent binding of PR to all tested H3 and H4
peptides without any preference for particular epigenetic modifi-
cation, indicating that PR is not acting as a bridging factor for the
binding of BAF complex to the K14 acetylated peptides (Figure 4A,
second row from the bottom). A similar behaviour was observed
Figure 2. PR forms a complex with BAF in T47D-MTVL cells and binds BAF57 in vitro. (A) Cells were untreated (2) or treated for 30 min
with R5020, lysed and immunoprecipitated either with a-PR antibody or with normal rabbit IgG as a negative control (IgG). Inputs and IPs were
analyzed by western blot using a-BAF57 and a-PR, as indicated. (B) Cells were treated as in (A). Inputs and IPs were analyzed by western blot using a-
BAF180, a-BAF250 and a-PR, as indicated. (C) Left: Scheme of wild type GST-BAF57 or GST-BAF57 deletion mutants used for pulldown assays. Right:
Coomassie-stained gel with the level of expression of the BAF57-GST fusion proteins. (D) Recombinant PR and either wild type GST-BAF57 or GST-
BAF57 deletion mutants were used for pulldown assays. Binding reactions were incubated with glutathione sepharose beads and eluted by boiling in
SDS sample buffer. Input and bound material were analyzed by western blot with a-PR.
doi:10.1371/journal.pgen.1000567.g002
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PLoS Genetics | www.plosgenetics.org 5 July 2009 | Volume 5 | Issue 7 | e1000567Figure 3. Acetylation on histone H3K14 by PCAF is essential for hormonal transactivation in T47D-MTVL cells. (A) Left: Cells were
transfected with the indicated siRNAs and the levels of PCAF, SRC1, and tubulin were determined by Western blotting. The asterisks indicate
inespecific bands. Right: Cells were transfected with the indicated siRNAs and treated with 10 nM R5020 for 6 h. RNA was extracted, cDNA was
generated and used as template for real time PCR with luciferase oligonucleotides. The values represent the mean and standard deviation from 3
experiments performed in duplicate. (B) Cells were transfected with siRNAs, treated with 10 nM R5020 as indicated and the levels of c-Fos and c-Myc
mRNAs were analyzed by RT–PCR. The values represent the mean and standard deviation from 2 experiments performed in duplicate. (C) Cells were
transfected with PCAF or PCAF HAT mutant (PCAFDHAT), treated with hormone as indicated and transcription from the MMTV promoter was
determined as in (B). An empty vector was used as control. The values represent the mean and standard deviation from 2 experiments performed in
duplicate. (D) Left: Cells transfected with the siRNAs and treated with hormone as indicated were subjected to ChIP assays with a-BAF57, a-BAF250
and a-K14acH3. The precipitated DNA fragments were subjected to PCR analysis to test for the presence of sequences corresponding to the MMTV
nucleosome B. A representative of three independent experiments is shown. Right: quantification of the results by real time PCR from two
experiments performed induplicate. (E) Cells were treated with R5020 as indicated and subjected to re-ChIP assays with a-H3K14ac and IgG (first IP)
followed by a-BAF250 for the second IP. Precipiated DNA was analysed by PCR for the presence of sequences corresponding to the MMTV, c-Fos and
c-Myc PR binding regions. (F) Cells were treated for 30 min with R5020, lysed and chromatin was immunoprecipitated either with a-H3K14ac or with
normal rabbit IgG as a negative control (IgG). IPs were analyzed by western blot using a-BAF155 and a-H3K14ac.
doi:10.1371/journal.pgen.1000567.g003
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PLoS Genetics | www.plosgenetics.org 6 July 2009 | Volume 5 | Issue 7 | e1000567Figure 4. The BAF complex binds preferentially to histone H3K14ac and promotes H2A displacement. (A) Nuclear extracts derived from
T47D-MTVL cells were used for pulldown experiments with the indicated H3 and H4 tail peptides coupled to beads. Immunoblotting was performed
for the presence of components of the BAF and PBAF complex, histone H1 and PR. (B) Cells were untreated (0) or treated for 5 and 30 min with 10 nM
R-5020 and subjected to ChIP assays with a-H4K8ac and a-H3K9ac specific antibodies. The precipitated DNA fragments were subjected to PCR
analysis to test for the presence of sequences corresponding to the MMTV nucleosome B. Input material (1%) is shown for comparison. A
representative of three independent experiments is shown. (C) Quantification of the interaction of selected human SWI/SNF subunits with the
indicated H3 tail acetylated peptides. SILAC ratios represent the relative abundance of the ‘heavy’ (modified) to the ‘light’ (unmodified) peptide. The
variation (in %) and the number of quantified peptides are indicated. (D) Left: T47D-MTVL cells were transfected with siRNAs and treated with
hormone as indicated, subjected to ChIP assays using a-NF1, a-PR and a-H2A and primers for MMTV nucleosome B. Right: quantification of the results
by real time PCR. A representative of three independent experiments is shown.
doi:10.1371/journal.pgen.1000567.g004
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not shown).
Next, we quantify the interaction of the BAF subunits to H3
acetylated peptides by stable isotope labeling by amino acids in cell
culture (SILAC) [45]. Nuclear extracts derived from human
HeLaS3 cells grown in light or heavy medium were incubated with
immobilized histone peptides in the nonacetylated (H3) and
acetylated form, respectively (Figure S3A). We identified BAF180,
BAF200, Brg1 and Brm as selective interactors for H3K9ac,
H3K14ac and H3K9acK14ac. The SILAC ratio (Heavy/Light,
that is modified/unmodified) for Brm was 1.8 for H3K9ac and 7.9
for H3K14ac (Figure 4C and Figure S3), indicating that BAF
complex is attached preferentially to K14 acetylated peptides and
confirming the results obtained with peptide pull downs
(Figure 4A). Higher SILAC ratios with H3K14ac peptide were
also obtained for Brg1 and for the PBAF specific subunits, BAF180
and BAF200 (Figure 4C). An additive effect on binding was
observed when the double modification H3K9acK14ac was used
(Figure 4C). However, we did not find an increase in H3K9ac on
the MMTV promoter following hormone induction (Figure 4B,
lower panel). These results highlight the role of K14 acetylation as
the main modification responsible for BAF and PBAF binding.
Knocking down Brg1 and Brm reduces the interaction of
BAF57 and BAF155 with H3K14ac peptides without affecting the
intracellular levels of their complex with BAF170 (Figure S4 and
data not shown), indicating that the bromodomains of the
ATPases contribute to the anchoring of the BAF complex at
H314Kac containing sites.
The BAF complex facilitates NF1 binding by mediating
histone H2A/H2B displacement
Next we used knockdown experiments to test whether BAF is
involved in NF1 binding to the MMTV promoter, a critical step in
hormonal induction [35]. The NF1 family of transcription factors
in vertebrates is composed of four different genes: NF1A, NF1B,
NF1C and NF1X [46], of which NF1C most abundantly
expressed in mammary gland and is involved in reciprocal and
sequential synergism with hormone receptors [47,48]. In control
cells, NF1C bound to the MMTV promoter in response to
hormone, while binding was diminished upon Brg1 and Brm
knockdown (Figure 4D, first row, compare lanes 1–2 vs 3–4;
quantification by real time PCR is shown in the right panel),
suggesting that BAF complexes are necessary for NF-1 to access
the promoter in response to hormone.
To investigate how BAF action facilitates NF1 binding we
investigated its involvement in the localized displacement of
histones H2A and H2B dimers, which is observed after hormone
induction [6]. In cells transfected with control siRNA, recruitment
of PR 30 minutes after hormone addition (Figure 4D, second row,
lanes 1–2) is accompanied by displacement of histone H2A
(Figure 4D, third row, lanes 1–2). Depletion of Brm and Brg1
diminished PR binding and abolished H2A displacement
(Figure 4D, lanes 3–4; quantification by real time PCR is shown
in the right panel). Thus, BAF complexes are required for PR
binding and H2A/H2B histone displacement, a requisite for NF1
binding. It is likely that the residual PR bound in the absence of
BAF corresponds to receptor interacting with the exposed HRE1
[27].
Discussion
The results of this study contribute to a better understanding of
the molecular mechanisms of promoter activation by progester-
one. We have shown previously that PR interacts with an exposed
HRE on the surface of a nucleosome on the MMTV promoter
[27] and recruits Brg1/Brm-containing complexes [6]. Here we
demonstrate the need of the hSWI/SNFa complex, known as
BAF, for activation of MMTV and other progesterone target
genes. We show that BAF is recruited at least in part via an
interaction between PR and the BAF57 subunit of the complex. In
a previous report we have described that acetylation of H3K14 in
response to progestins [30]. Now we show that H3K14ac, likely
generated by PCAF, anchors the BAF complex, suggesting a
mechanism for the cooperation between two types of chromatin
remodeling activities. The recruited BAF catalyzes the ATP
dependent displacement of histones H2A/H2B needed for NF1 to
gain access to the promoter site. Thus synergism between the two
transcription factors PR and NF1 is mediated by a cooperation
between two chromatin remodeling machines, BAF and PCAF.
BAF interacts with PR and is necessary for induction of
progesterone target genes in breast cancer cells
Activation of several hormone sensitive promoters exhibits
SWI/SNF-dependence reflecting the requirement of chromatin
remodeling [40,49–51]. There is evidence that glucocorticoid
receptor recruits a Brg1-containing complex to promoters via
protein-protein interaction with BAF250 [40], whereas androgen
receptor (AR) and ERa can directly bind BAF57 [39,51]. We have
described a progesterone dependent recruitment of Brg1 and Brm
to the MMTV promoter in breast cancer cells and have shown
that yeast SWI/SNF can displace H2A/H2B dimers from MMTV
recombinant nucleosomes [6], but the nature of the complex
recruited in intact cells and its function in gene activation was not
known.
The human SWI/SNF complexes can have either Brm or Brg1
as ATPase subunits [52]. Although the two ATPases exhibit
certain differences in their biological activities [53,54], they can
partly compensate for each other in mouse cells [55]. We found
that in T47D-MTVL cells depletion of Brm increases Brg1 levels
and viceversa. This could be due to the existence of an excess of
both free ATPases in equilibrium with the complex bound forms.
If one of the ATPase is depleted the other will be incorporated to a
higher extent in the SWI/SNF complex thus becoming more
resistant to proteolytic degradation. A similar finding has been
reported in mice lacking Brm [56].
The BAF complex is recruited to the MMTV promoter within
minutes after progestin treatment, likely through a direct
interaction with the activated PR. The fact that PR was unable
to form a complex with PBAF indicates that the receptor can
discriminate between these two related machineries and promotes
BAF recruitment to progestin target promoters. Although BAF57
is present in BAF and PBAF complexes it is possible that hormone-
dependent interaction with PR is only possible in the context of the
BAF complex. Similar results have been previously reported for
AR and ERa [38,39,51]. Depletion of BAF250 has a similar effect
on MMTV induction as depletion of both Brg1 and Brm,
confirming the importance of the BAF complex. BAF dependence
is observed with other progesterone responsive genes, such as FOS
and MYC, indicating that chromatin remodeling by BAF plays a
more general role in progesterone gene regulation. However, as
exemplified by the cyclin D1 gene, not all hormone responsive
genes required BAF for induction, indicating the existence of
alternative pathways for hormonal gene regulation. It is likely that
other ATP-dependent remodeling complexes participate in
regulation of MMTV and other progesterone regulated genes.
In minichromosomes reconstituted in Drosophila embryo extracts
NURF mediates synergism between recombinant PR and NF1 in
a SWI/SNF independent manner [35]. The difference with our
BAF and PCAF Cooperate in MMTV Induction
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breast cancer cells and Drosophila embryo, such as lack of linker
histones and transcriptional activity. We know that hSnf2H is
recruited to the MMTV promoter 30 min after progesterone
treatment of T47D-MTVL cells but its role in hormonal induction
remains to be established [30].
Acetylation on histone H3K14 by PCAF is essential for
hormonal induction by anchoring BAF to the promoter
The role of histone acetylation on MMTV activity has been
controversial. We have observed that low concentration of HDAC
inhibitors leading to moderate increase in acetylation, enhance
MMTV transcription [37], whereas high concentrations com-
pletely abolish transcription [37,57]. In previous reports, we have
demonstrated the co-recruitment of PCAF and SRC1 to the
MMTV promoter following progestin treatment [6,30]. The
siRNA knockdown results presented here demonstrate that PCAF
is one of the main HATs acting on the MMTV promoter, that its
levels correlated with the extent of H3K14 acetylation, and that
acetylation is necessary and important for progesterone activation
of the MMTV promoter.
There have also been controversies over the nature of the
histone modifications influencing binding of the SWI/SNF
complex [58]. It was first claimed that acetylation of H4K8
recruits the SWI/SNF complex via Brg1, whereas acetylation of
H3K9 and H3K14 is only important for the recruitment of TFIID
general transcription factors [43]. Two independent recent reports
demonstrated that the bromodomain-containing ATPase Brg1 has
the highest binding affinity to acetylated H3K14 peptide or doubly
acetylated H3K9/K14 peptide, whereas binding to acetylated
H4K8 peptide is insignificant [59,60]. Although H4 acetylation
takes place very early after progesterone addition to T47D-MTVL
cells (Figure 4B), we found here no binding of the BAF complex to
acetylated H4 peptides (Figure 4A). In contrast, we show that
components of the BAF complex bind to peptides containing
acetylated H3K14, alone or in combination with other histone
modifications. Furthermore, we quantify the interaction of
components of BAF and PBAF to H3 acetylated peptides by
SILAC. Our results indicate that compared to H3K9ac, H3K14ac
is the major contributor to anchoring of these chromatin-
remodeling complexes to nucleosomes. Several subunits of BAF
and PBAF contain bromodomains that can bind acetylated
residues. Obvious candidates are Brg1 and Brm, but other
subunits, such as BAF180, could cooperate on the recognition of
H3K14ac by PBAF. Despite the fact that both BAF and PBAF can
bind acetylated K14, only BAF is recruited to the MMTV
promoter, indicating that H3K14ac participates in anchoring or
retention of the recruited complex but is not sufficient for
recruitment.
The colocalization of BAF and H3K14ac (Figure 3F) could
reflect a general role of this histone mark to BAF anchoring in
chromatin, but other explanations are possible. For instance, a
common transcription factor could recruit BAF and HATs to the
same chromatin regions. Alternatively, components of the BAF
complex could be important for HATs recruitment. A combina-
tion of these hypotheses is also possible.
BAF mediates nucleosome remodeling leading to H2A/
H2B displacement that facilitates NF1 binding
Following hormone treatment, PR is phosphorylated, forms a
complex with activated Erk and Msk1 and this ternary complex
binds the exposed HRE1 on the surface of the MMTV promoter
nucleosome leading to modification of the H3 tail and displace-
ment of a repressive complex [30]. PCAF is also recruited to the
promoter and acetylation of H3K14 is observed 5 min after
hormone treatment [30]. The activated ternary complex pPR-
pErk-pMsk1 recruits BAF that initiates nucleosome remodeling,
since inhibiting Erk or Msk1 activation blocks BAF recruitment
and the subsequent steps. We have not addressed the initial
kinetics of acetylation and BAF recruitment in sufficient detail and
cannot propose a precise order of events. Moreover, we cannot
exclude that PCAF interacts with BAF and that both complexes
are recruited together.
In T47D-MTVL cells the BAF mediated chromatin remodeling
event is a localized displacement of dimers of H2A/H2B from
promoter nucleosome B, a catalytic activity exhibited by the
purified yeast SWI/SNF complex on recombinant MMTV
nucleosomes [6]. An earlier study with recombinant nucleosomes
and SWI/SNF complexes from yeast suggest that both BAF and
PBAF complexes would have the capacity to displace histones
H2A/H2B as they share the relevant subunit, Swi3p [36]. This
remodeling event is a prerequisite for enabling access of NF1 to its
binding site in the MMTV promoter following hormone
treatment, as demonstrated by the lack of H2A displacement
and NF1 binding in BAF-depleted cells. We have previously
shown that NF1 binding stabilizes the open conformation of the
nucleosome allowing binding of further PR molecules to the
internal HREs and subsequent activation of transcription [35]. A
model representing our present view of the initial steps in
progesterone activation of the MMTV promoter is shown in
Figure 5. The model underlines the feed-forward cyclical nature of
the activation process and explains why interfering with any of the
initial steps has consequences for binding of all factors involved,
PR, NF1, BAF and PCAF.
Briefly, after hormone induction activated PR binds first to the
exposed HRE1 in a process that does not require chromatin
remodeling, as this site is accessible [28]. Along with the activated
PR, kinases, BAF and PCAF are recruited to the promoter
chromatin. Histone H3 S10 phosphorylation and K14 acetylation
promote displacement of an HPIc-containing repressive complex
[30] and BAF anchoring, respectively. Now, BAF can displace
histones H2A/B and thus facilitate NF1 binding. Bound NF1
stabilize the open conformation of the remodeled nucleosome
exposes the previously hidden HREs allowing binding of further
PR-BAF-kinases complexes and PCAF. Binding of PR to these
previously hidden HREs is critical for the MMTV activation.
Finally, it is worth noting that we have not mentioned in these
studies the possible role of linker histones. Our previous results
[61] and those of other groups [62–64], suggest that changes
histone H1 stoichiometry and phosphorylation by CyclinA/Cdk2
take place at different time points during the hormonal induction
and are important for transcriptional activation. Future studies will
be required to clarify the relationship of these changes to those
reported in this study.
Materials and Methods
Cell culture and hormone treatments
T47D-MTVL breast cancer cells carrying one stably integrated
copy of the luciferase reporter gene driven by the MMTV
promoter [27] were routinely grown in RPMI 1640 medium
supplemented with 10% FBS, 2 mM L-glutamine, 100 U/ml
penicillin and 100 mg/ml streptomycin. For the experiments, cells
were plated in RPMI medium without phenol red supplemented
with 10% dextran-coated charcoal treated FBS (DCC/FBS) and
48 h later medium was replaced by fresh medium without serum.
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PLoS Genetics | www.plosgenetics.org 9 July 2009 | Volume 5 | Issue 7 | e1000567Figure 5. Model for the initial steps of MMTV promoter activation. Before hormone addition the MMTV promoter is silent and associated
with a repressive complex that includes HP1c (step 1). After hormone addition the activated complex of pPR-pErk-pMsk, as well as PCAF and BAF, are
recruited to the MMTV promoter. For simplicity PR is shown as a monomer, though the active form is a homodimer. Msk and PCAF phosphoacetylates
H3 leading to H3S10phK14ac (step 2). This modification displaces the repressive complex and anchors the BAF complex, enabling ATP-dependent
H2A/H2B displacement (step 3). The nucleosome opening facilitates NF1 binding generating a stable platform that exposes previously hidden HREs
for the recruitment of additional PR and BAF complexes, coactivator and eventually promoter activation (step 4). Depletion of BAF prevents
progression of the activation process to step 2: no histone displacement is observed, NF1 cannot bind and consequently less PR/BAF complexes are
bound to the promoter. Depletion of PCAF has a similar effect, most likely by labilization of BAF binding, blocking the activation process at step 2.
doi:10.1371/journal.pgen.1000567.g005
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R5020 (10 nM) or vehicle (ethanol) for different times at 37uC.
Transient transfections
Cells were cultured into 6-well plates at a density of 4610
5
cells/well and treated as indicated above. Transient transfections
were performed using Lipofectamine 2000 (Invitrogen). cDNAs
expressing PCAF and its deacetylase defective mutant (PCAF
DHAT) were kindly provided by Tony Kouzarides (Cambridge,
UK).
Chromatin Immunoprecipitation (ChIP) and re-ChIP
assays in cultured cells
ChIP assays were performed as described [65] using the NF1
specific antibody (gift from Dr Naoko Tanese), the H2A antibody
(gift from Stefan Dimitrov), anti-BAF180 (gift from Dr Weidong
Wang), anti-PR(H190) and anti-Brg1(H88), both from Santa Cruz,
anti-SMARCA2/BRM (ab15597) from Abcam, anti-BAF57/
SMARCE1 from Bethyl and anti-acetyl(Lys14)-Histone H3 and
anti-BAF250 from Upstate. Quantification of chromatin immuno-
precipitation was performed by real time PCR using Roche
Lightcycler (Roche). The fold enrichment of target sequence in
the immunoprecipitated (IP) compared to input (Ref) fractions was
calculated using the comparative Ct (the number of cycles required
to reach a threshold concentration) method with the equation
2
Ct(IP)2Ct(Ref). Each of these values were corrected by the human b-
globin gene and referred as relative abundance over time zero.
Primers sequences are available on request. For re-ChIP assays,
immunoprecipitations were sequentially washed as previously
described [66]. Complexes were eluted with 10 mM DTT at
37uC for 30 min, diluted 50 times with dilution buffer, and
immunoprecipitated with the indicated antibodies. The antibodies
used for ChIPs assays are listed in Figure S5.
RNA interference experiments
All siRNAs were transfected into the T47D-MTVL cells using
Lipofectamine 2000 (Invitrogen). After 48 h the medium was
replaced by fresh medium without serum. After one day in serum-
free conditions, cells were incubated with R5020 (10 nM) or
vehicle (ethanol) for different times at 37uC. The down-regulation
of Brg1, Brm, NF1, BAF57, BAF250, PCAF and SRC1 expression
was determined by Western blotting. The siRNAs used are listed
in Figure S5.
RNA extraction and RT–PCR
Total RNA was prepared and cDNA generated as previously
described [30]. Quantification of LUC and GAPDH gene
products was performed by real time PCR. Each value calculated
using the standard curve method was corrected by the human
GAPDH and expressed as relative RNA abundance over time
zero. Primer sequences are available on request.
Coimmunoprecipitation assay
Cells were lysed and cell extracts (2 mg) were incubated with
protein G/A agarose beads previously coupled with 6 mg of the
corresponding antibodies or an unspecific control antibody. The
immunoprecipitated proteins (IP) were eluted by boiling in SDS
sample buffer. Inputs and IPs were analyzed by western blot using
BRG1, BRM, BAF155, BAF170 and H3K14ac specific antibodies.
Peptide pull down assays
Nuclear extracts from T47DMTVL breast cancer cells were
prepared as described [67]. Peptide pull down assays were
performed as described previously [68], with the exception of
using 100 mg of nuclear extract during incubation of peptide-
bound beads. Synthetic biotinylated H3 and H4 peptides were
either purchased from Upstate or were kind gifts from M.
Vermeulen. For Western immunoblotting, antibodies against
BRG1, BAF170, BAF155, PR (Santa Cruz), BRM (Abcam),
BAF57, SNF5 (Bethyl) and H1 (Upstate 05-457) were used.
Mass spectrometry of proteins
After trypsin digestion of gel slices peptides were extracted,
desalted using stage tips [69] and analyzed using a nano-HPLC
Agilent 1100 nanoflow system connected online to an LTQ-
Orbitrap mass spectrometer (Thermo Fisher, Bremen). The mass
spectrometer was operated in the data-dependent mode to
automatically switch between MS and MS
2. The instrument was
operated with ‘lock mass option’ as recently described [70]. Survey
spectra were acquired with 60,000 resolution in the orbitrap, while
acquiring up to five tandem mass spectra in the LTQ part of the
instrument. The raw data files were analyzed with an in-house
developed quantitative proteomics software MaxQuant, version
1.0.12.5 [71], in combination with the Mascot search engine
(Matrix Science). The data was searched against a decoy human
IPI database 3.37 including common contaminants. False
discovery rates, both at the peptide and protein level were set to
1%. Minimal peptide length was set to 6 amino acids. False
positive rates for peptides are calculated as described in [72].
Supporting Information
Figure S1 Differential expression of BAF proteins in T47D-
MTVL breast cancer cells. Nuclear extracts from T47D-MTVL
cells were analyzed by western blotting with antibodies specific for
the individual BAF proteins.
Found at: doi:10.1371/journal.pgen.1000567.s001 (0.39 MB TIF)
Figure S2 Knock down of BAF180 does not affect MMTV
transcriptional activity. (A) BAF180 is recruited to the RARb2
promoter. U937 cells (human promyelocitic leukemia cell line)
were untreated (2) or treated (+) for 4 hs with retinoic acid (RA)
and subjected to ChIP assays with BAF200 and BAF180 specific
antibodies. The precipitated DNA fragments were subjected to
PCR analysis to test for the presence of sequences from 2665 to
2308 corresponding to the RARb2 promoter. Lower Panel:
expression of BAF180 and BAF200 proteins in U937 cells. (B)
Knock down of BAF180 does not affect MMTV transcriptional
activity. Left: T47D-MTVL cells were transfected either with
control siRNA or with siRNA against BAF180. After 48 h the
medium was replaced by fresh medium without serum. After one
day in serum-free conditions, cells were lysed and the levels of BAF
180 and tubulin were determined by Western blotting. Right:
T47D-MTVL cells were transfected with Control or BAF 180
siRNAs in RPMI medium and cultured for 48 h. After one day in
serum-free conditions, cells were incubated with 10 nM R5020 for
2 hs and total RNA was prepared, cDNA was generated and used
as template for real time PCR with specific Luciferase and
GAPDH primers. Each luciferase mRNA value was corrected by
the GAPDH mRNA level and is expressed as relative RNA
abundance over time zero. The values represent the mean and
standard deviation from 3 experiments performed in duplicate.
Found at: doi:10.1371/journal.pgen.1000567.s002 (0.17 MB TIF)
Figure S3 Schematic representation of the SILAC-based histone
pull down approach. (A) SILAC peptide pull-down using
unmodified H3 (grey ovals), H3K9ac (B, blue ovals), and
H3K14ac (C, red ovals) peptide. The spectra show the relative
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(4) to unmodified and modified peptides.
Found at: doi:10.1371/journal.pgen.1000567.s003 (1.17 MB TIF)
Figure S4 Brg1 and Brm are required for the interaction of BAF
and PBAF complexes with the H3K14ac mark. (A) Nuclear
extracts derived from T47D-MTVL cells transfected with control
and Brg1 and Brm siRNAs were used for pulldown experiments
with the indicated H3 tail peptides coupled to beads. Immuno-
blotting was performed for the presence of BAF57 and H1. (B)
Nuclear extracts derived from T47D-MTVL cells transfected with
control and Brg1 and Brm siRNAs were used for immunoprecip-
itation either with BAF57 antibody or with normal rabbit IgG as a
negative control (IgG). The immunoprecipitates (IP) were
analyzed by western blotting with BAF155 and BAF170 specific
antibodies.
Found at: doi:10.1371/journal.pgen.1000567.s004 (0.22 MB TIF)
Figure S5 siRNAs and antibodies used for ChIP assays in the
present study.
Found at: doi:10.1371/journal.pgen.1000567.s005 (0.67 MB TIF)
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